About admin

This author has not yet filled in any details.
So far admin has created 66 blog entries.

New publication on Duloxetine exposure

2021-07-12T10:11:32+02:00July 12th, 2021|Categories: Uncategorised|

The aim of the study is to evaluate the association between duloxetine exposure during pregnancy and spontaneous as well as elective abortions. The full article can be found here: Link    Abstract Background: Depression and antidepressant treatment are widespread among women of childbearing age. Objective: This study evaluates the association between duloxetine exposure during pregnancy and spontaneous [...]

Read the publication on diabetes treatment and the SWEET-project

2021-05-10T09:58:52+02:00May 10th, 2021|Categories: News|

Read this publication published in Diabetes Technology & Therapeutics. This publication aims to study the impact of treatment changes by analyzing selected quality indicators from the initial SWEET database over the past decade. You will find the abstract below and the full article on this link    Abstract Objective: The international SWEET registry (NCT04427189) was initiated [...]

ApHER in a cooperation with EasyTrial ApS and IWA Consulting ApS

2021-04-12T16:29:21+02:00April 12th, 2021|Categories: News|

ApHER has entered a new cooperation with EasyTrial ApS and IWA Consulting ApS. This cooperation aims to support our customers throughout the several phases of Medical Device production by offering qualified advice and guidance in respect of regulatory compliance. This is especially important due to the new European Medical Device Regulation 2017/745, which will come into [...]

MedEngine acquires ApHER to offer Nordic real-world data solutions to global pharmaceutical companies

2021-04-12T16:30:57+02:00March 4th, 2021|Categories: News|

Helsinki, Finland – March 4th, 2021. MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company. The companies will combine their scientific expertise and profound understanding of Nordic health data to provide advanced real-world data solutions to the global pharmaceutical industry. [...]

ApHER presented a poster at ESMO 2020

2020-09-23T17:57:01+02:00September 23rd, 2020|Categories: Uncategorised|

ApHER presented a poster “Treatment patterns and survival for small cell lung cancer patients: A nationwide Danish register study” at the annual meeting of the European Society for Medical Oncology, ESMO2020, held as a virtual event 17-20 September 2020. Check also these articles (in Danish) on our work in Dagens Medicin and Onkologisk Tidsskrift: Article in [...]

New ApHER publication

2020-08-19T10:25:40+02:00August 19th, 2020|Categories: Uncategorised|

Take a look at our most recent publication published in the journal BMC Cardiovascular Disorders. The study aimed to evaluate low-density lipoprotein cholesterol goal attainment and lipid-lowering therapy intensity in patients with coronary syndrome in order to reduce the risk of further cardiac events. You can read the abstract below or follow this link to read [...]

Welcome to ApHER News

2020-08-19T11:10:10+02:00June 7th, 2020|Categories: Newsletter|

Who we are ApHER is an independent academic research organization and partner of the EnCEPP network. ApHER has provided evidence based research for decision making in the health care system, medical device and pharmaceutical development policy since 2009. We are your long term trusted partner. We conduct research and analyses which will provide decision support [...]

Take a look at our most recent publication

2020-05-20T13:28:56+02:00April 24th, 2020|Categories: Uncategorised|

Have a look at our most recent publication published in the Pharmacoepidemiology & Drug Safety journal. The study combines Nordic register data from Denmark, Finland and Sweden with the purpose of comparing users of Finasteride treatment with nonusers. You can read the abstract below, or follow this link to order access to the full article. Abstract [...]

Prof. Anders Green – Appointed Member of the International Scientific Board of the Dasman Diabetes Institute

2021-04-12T16:34:19+02:00March 6th, 2020|Categories: News|

As of April 1st 2020, Professor Anders Green has been appointed Member of the International Scientific Board of the Dasman Diabetes Institute, Kuwait. The Institute is one of the leading centres in the Middle East for treatment, training and research in diabetes which constitutes a dramatically rising and alarming health problem in the region. As a [...]


2020-05-01T17:25:52+02:00November 20th, 2019|Categories: Cancer|

ApHER has presented results from the CEDAR Study in the poster “The past, present, and future of prostate cancer incidence, mortality and prevalence in Denmark during 2006 through 2030” at the 11th European Multidisciplinary Congress on Urological Cancer (EMUC19) 15-17 November, 2019.